Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.795
-0.115 (-6.02%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $38.71 million as of April 29, 2025. Its market cap has increased by 49.45% in one year.
Market Cap
38.71M
Enterprise Value
25.84M
1-Year Change
49.45%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $38.71M, a decrease of -75.64%. That is a compound annual growth rate of -16.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 28, 2025 | 38.70M | -22.29% |
Dec 31, 2024 | 49.80M | 260.87% |
Dec 29, 2023 | 13.80M | 27.78% |
Dec 30, 2022 | 10.80M | -78.82% |
Dec 31, 2021 | 51.00M | 20.57% |
Dec 31, 2020 | 42.30M | 166.04% |
Dec 31, 2019 | 15.90M | 28.23% |
Dec 31, 2018 | 12.40M | -92.01% |
Dec 29, 2017 | 155.10M | -2.39% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 787.80B |
UnitedHealth Group | 382.29B |
Johnson & Johnson | 373.78B |
AbbVie | 340.25B |
Novo Nordisk | 280.41B |
Abbott Laboratories | 224.65B |
AstraZeneca | 218.53B |
Novartis AG | 214.73B |